Copy Number Variant Detection Using Next-Generation Sequencing

Alexander Nord, Stephen J. Salipante, Colin Pritchard

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Copy number variation refers to imbalanced structural variation resulting in gain or loss of genomic DNA in a region ranging from tens to millions of bases long. Copy number variants (CNVs) are a critical class of genetic variation in clinical next-generation sequencing (NGS) due to their wide-ranging impacts in human disease. The variety and complexity of methods used to detect CNVs in NGS data can be daunting. This chapter will summarize general approaches to CNV detection from NGS data, application of such methods across diverse clinical NGS applications, and screening of CNVs to identify causal variants in human disease. We briefly describe the origins and the functional significance of CNVs and review non-NGS CNV detection technologies. Considerations of CNV screening across various clinical NGS contexts are discussed, including candidate gene, exome, whole genome, and cell-free DNA sequencing applications. The main conceptual approaches to CNV discovery in NGS data are reviewed in detail, including mate pair alignment, relative depth of coverage, and direct assembly or sequence-based evidence from split reads. CNV detection methods are highly design- and platform-dependent, requiring customization and trade-offs for specific approaches. We discuss the strengths and weaknesses of different CNV detection approaches in the context of both capture-based and whole genome sequencing platforms, highlighting considerations for germline DNA, tumor tissue, and cell-free tumor or fetal DNA. We discuss the availability of reference standards for benchmarking CNV detection by NGS methods. Finally, we cover orthogonal validation technologies toward the goal of incorporating clinically actionable NGS-based CNV detection for patient care.

Original languageEnglish (US)
Title of host publicationClinical Genomics
PublisherElsevier Inc.
Pages165-187
Number of pages23
ISBN (Electronic)9780124051737
ISBN (Print)9780124047488
DOIs
StatePublished - Nov 7 2014

Fingerprint

DNA
Genome
Exome
Technology
Benchmarking
DNA Sequence Analysis
Neoplasms
Patient Care
Genes

Keywords

  • Array comparative genomic hybridization
  • Copy number variants
  • Next-generation sequencing

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Nord, A., Salipante, S. J., & Pritchard, C. (2014). Copy Number Variant Detection Using Next-Generation Sequencing. In Clinical Genomics (pp. 165-187). Elsevier Inc.. https://doi.org/10.1016/B978-0-12-404748-8.00011-3

Copy Number Variant Detection Using Next-Generation Sequencing. / Nord, Alexander; Salipante, Stephen J.; Pritchard, Colin.

Clinical Genomics. Elsevier Inc., 2014. p. 165-187.

Research output: Chapter in Book/Report/Conference proceedingChapter

Nord, A, Salipante, SJ & Pritchard, C 2014, Copy Number Variant Detection Using Next-Generation Sequencing. in Clinical Genomics. Elsevier Inc., pp. 165-187. https://doi.org/10.1016/B978-0-12-404748-8.00011-3
Nord A, Salipante SJ, Pritchard C. Copy Number Variant Detection Using Next-Generation Sequencing. In Clinical Genomics. Elsevier Inc. 2014. p. 165-187 https://doi.org/10.1016/B978-0-12-404748-8.00011-3
Nord, Alexander ; Salipante, Stephen J. ; Pritchard, Colin. / Copy Number Variant Detection Using Next-Generation Sequencing. Clinical Genomics. Elsevier Inc., 2014. pp. 165-187
@inbook{3f7ee1d533604b3b85e4f3dc3a88a935,
title = "Copy Number Variant Detection Using Next-Generation Sequencing",
abstract = "Copy number variation refers to imbalanced structural variation resulting in gain or loss of genomic DNA in a region ranging from tens to millions of bases long. Copy number variants (CNVs) are a critical class of genetic variation in clinical next-generation sequencing (NGS) due to their wide-ranging impacts in human disease. The variety and complexity of methods used to detect CNVs in NGS data can be daunting. This chapter will summarize general approaches to CNV detection from NGS data, application of such methods across diverse clinical NGS applications, and screening of CNVs to identify causal variants in human disease. We briefly describe the origins and the functional significance of CNVs and review non-NGS CNV detection technologies. Considerations of CNV screening across various clinical NGS contexts are discussed, including candidate gene, exome, whole genome, and cell-free DNA sequencing applications. The main conceptual approaches to CNV discovery in NGS data are reviewed in detail, including mate pair alignment, relative depth of coverage, and direct assembly or sequence-based evidence from split reads. CNV detection methods are highly design- and platform-dependent, requiring customization and trade-offs for specific approaches. We discuss the strengths and weaknesses of different CNV detection approaches in the context of both capture-based and whole genome sequencing platforms, highlighting considerations for germline DNA, tumor tissue, and cell-free tumor or fetal DNA. We discuss the availability of reference standards for benchmarking CNV detection by NGS methods. Finally, we cover orthogonal validation technologies toward the goal of incorporating clinically actionable NGS-based CNV detection for patient care.",
keywords = "Array comparative genomic hybridization, Copy number variants, Next-generation sequencing",
author = "Alexander Nord and Salipante, {Stephen J.} and Colin Pritchard",
year = "2014",
month = "11",
day = "7",
doi = "10.1016/B978-0-12-404748-8.00011-3",
language = "English (US)",
isbn = "9780124047488",
pages = "165--187",
booktitle = "Clinical Genomics",
publisher = "Elsevier Inc.",

}

TY - CHAP

T1 - Copy Number Variant Detection Using Next-Generation Sequencing

AU - Nord, Alexander

AU - Salipante, Stephen J.

AU - Pritchard, Colin

PY - 2014/11/7

Y1 - 2014/11/7

N2 - Copy number variation refers to imbalanced structural variation resulting in gain or loss of genomic DNA in a region ranging from tens to millions of bases long. Copy number variants (CNVs) are a critical class of genetic variation in clinical next-generation sequencing (NGS) due to their wide-ranging impacts in human disease. The variety and complexity of methods used to detect CNVs in NGS data can be daunting. This chapter will summarize general approaches to CNV detection from NGS data, application of such methods across diverse clinical NGS applications, and screening of CNVs to identify causal variants in human disease. We briefly describe the origins and the functional significance of CNVs and review non-NGS CNV detection technologies. Considerations of CNV screening across various clinical NGS contexts are discussed, including candidate gene, exome, whole genome, and cell-free DNA sequencing applications. The main conceptual approaches to CNV discovery in NGS data are reviewed in detail, including mate pair alignment, relative depth of coverage, and direct assembly or sequence-based evidence from split reads. CNV detection methods are highly design- and platform-dependent, requiring customization and trade-offs for specific approaches. We discuss the strengths and weaknesses of different CNV detection approaches in the context of both capture-based and whole genome sequencing platforms, highlighting considerations for germline DNA, tumor tissue, and cell-free tumor or fetal DNA. We discuss the availability of reference standards for benchmarking CNV detection by NGS methods. Finally, we cover orthogonal validation technologies toward the goal of incorporating clinically actionable NGS-based CNV detection for patient care.

AB - Copy number variation refers to imbalanced structural variation resulting in gain or loss of genomic DNA in a region ranging from tens to millions of bases long. Copy number variants (CNVs) are a critical class of genetic variation in clinical next-generation sequencing (NGS) due to their wide-ranging impacts in human disease. The variety and complexity of methods used to detect CNVs in NGS data can be daunting. This chapter will summarize general approaches to CNV detection from NGS data, application of such methods across diverse clinical NGS applications, and screening of CNVs to identify causal variants in human disease. We briefly describe the origins and the functional significance of CNVs and review non-NGS CNV detection technologies. Considerations of CNV screening across various clinical NGS contexts are discussed, including candidate gene, exome, whole genome, and cell-free DNA sequencing applications. The main conceptual approaches to CNV discovery in NGS data are reviewed in detail, including mate pair alignment, relative depth of coverage, and direct assembly or sequence-based evidence from split reads. CNV detection methods are highly design- and platform-dependent, requiring customization and trade-offs for specific approaches. We discuss the strengths and weaknesses of different CNV detection approaches in the context of both capture-based and whole genome sequencing platforms, highlighting considerations for germline DNA, tumor tissue, and cell-free tumor or fetal DNA. We discuss the availability of reference standards for benchmarking CNV detection by NGS methods. Finally, we cover orthogonal validation technologies toward the goal of incorporating clinically actionable NGS-based CNV detection for patient care.

KW - Array comparative genomic hybridization

KW - Copy number variants

KW - Next-generation sequencing

UR - http://www.scopus.com/inward/record.url?scp=84941915150&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84941915150&partnerID=8YFLogxK

U2 - 10.1016/B978-0-12-404748-8.00011-3

DO - 10.1016/B978-0-12-404748-8.00011-3

M3 - Chapter

AN - SCOPUS:84941915150

SN - 9780124047488

SP - 165

EP - 187

BT - Clinical Genomics

PB - Elsevier Inc.

ER -